GlassScriptPhysician profile
Michael Faulkner
NPI 1336342427
$12,752.94
in general payments reported to CMS, 2019-2025
32 companies · $785 in 2025
The $785 reported for 2025 was less than what a typical Interventional Cardiology provider received nationally (typical 2025 total: $1,092).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $3,837 · 2020: $672 · 2021: $1,844 · 2022: $1,211 · 2023: $2,505 · 2024: $1,898 · 2025: $785.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $4,452 · Travel and Lodging: $737.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $4,452.14 |
| Travel and Lodging | $736.56 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbott Laboratories | $1,938.88 | 2019-2025 | Mitraclip, Cardiomems |
| Medtronic Vascular, INC. | $1,784.97 | 2019-2020 | |
| Edwards Lifesciences Corporation | $1,398.04 | 2019-2025 | Pascal, Edwards Sapien 3 Ultra Transcatheter Heart Valve, Sapien 3 Ultra Resilia |
| Medtronic, INC. | $1,376.59 | 2021-2025 | Linq II |
| Novartis Pharmaceuticals Corporation | $1,055.06 | 2019-2025 | |
| Boston Scientific Corporation | $605.54 | 2019-2025 | Watchman Access System, Watchman, Watchman Flx |
| Zoll Services LLC (A/K/A Zoll Lifecor Corp) | $597.10 | 2019-2025 | Lifevest |
| Inari Medical, INC. | $548.10 | 2021-2025 | Ct Thrombectomy System Kit, Flowtriever Catheter, S |
| Pfizer INC. | $511.30 | 2019-2025 | |
| Astrazeneca Pharmaceuticals LP | $395.71 | 2019-2022 | |
| Janssen Pharmaceuticals, INC | $394.56 | 2019-2024 | Xarelto |
| Abiomed | $362.57 | 2019-2025 | Impella |
| Boehringer Ingelheim Pharmaceuticals, INC. | $347.97 | 2019-2024 | Jardiance |
| E.R. Squibb & Sons, L.L.C. | $341.91 | 2019-2025 | Camzyos, Eliquis |
| Amgen INC. | $321.89 | 2019-2025 | Repatha, Repatha |
Show all 32 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Sanofi-Aventis U.S. LLC | $129.34 | 2019 | |
| Lantheus Medical Imaging, INC. | $108.05 | 2019-2024 | Definity |
| Astellas Pharma US INC | $91.27 | 2019 | |
| Shockwave Medical, INC | $78.72 | 2022-2025 | Shockwave Intravascular Lithotripsy (Ivl) System With The Shockwave C2+ Coronary |
| Philips North America LLC | $75.55 | 2022-2024 | (6311) Epiq Cvx, (Ck7) Extended Holter, (Ck4) Mcot |
| Irhythm Technologies, INC. | $49.75 | 2019 | |
| Braemar Manufacturing, LLC | $38.88 | 2019 | |
| Otsuka America Pharmaceutical, INC. | $31.41 | 2025 | Rexulti |
| Merck Sharp & Dohme LLC | $31.04 | 2024-2025 | Verquvo |
| Elutia, INC. | $25.50 | 2019 | |
| Kiniksa Pharmaceuticals International, Plc | $23.78 | 2024 | Arcalyst |
| Alnylam Pharmaceuticals INC. | $17.67 | 2024 | Onpattro |
| Actelion Pharmaceuticals US, INC. | $16.87 | 2022 | |
| Biosense Webster, INC. | $16.57 | 2022 | |
| Inspire Medical Systems, INC. | $13.59 | 2024 | Inspire |
| Arbor Pharmaceuticals, INC. | $12.97 | 2019 | |
| Portola Pharmaceuticals, LLC | $11.79 | 2020 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Michael Faulkner listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.